Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Safety, Efficacy and Total Cost of Point-of-care Manufact... | ResearchHub
Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Safety, Efficacy and Total Cost of Point-of-care Manufactured anti-CD19 CAR T-cell Therapy in India: VELCART trial
0
Authors
Hamenth Palani
18 more
Hamenth Palani
•
Arun Arunachalam
16 more
•
Vikram Mathews
Published
March 1, 2025
Paper
Conversation
0
Reviews
0
Bounties
0
Abstract
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
Deleted Journal
Topics
Chemistry
Biochemistry
Medicine
Cancer Oncology
Immunology
Show all topics
DOI
10.1016/j.omton.2025.200977
License
CC-BY
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
Deleted Journal
Topics
Chemistry
Biochemistry
Medicine
Cancer Oncology
Immunology
Show all topics
DOI
10.1016/j.omton.2025.200977
License
CC-BY
